Meningitis Outbreak

Debate between Kirsty Blackman and Wes Streeting

Tuesday 17th March 2026 Commons Chamber

[Wes Streeting]

I thank my hon. Friend for sharing his awful experience, and for once again emphasising the importance of good public health information and advice, including for parents whose students will still be in Canterbury and who may therefore be particularly worried. UKHSA is now advising anyone who visited Club Chemistry on 5, 6 or 7 March to come forward for preventive antibiotic treatment as a precautionary measure; it can be collected from four sites. If they or people they know develop symptoms of meningitis or septicaemia, they should urgently seek medical help by going to the nearest accident and emergency department or dialling 999. If it is not an emergency but people are concerned, they can contact their GP or NHS 111.

Symptoms of meningitis and septicaemia can include a rash that does not fade when pressed with a glass; a sudden onset of high fever; a severe and worsening headache; a stiff neck; vomiting and diarrhoea; joint and muscle pain; a dislike of bright lights; very cold hands and feet; seizures; confusion or delirium; and extreme sleepiness or difficulty waking. I want to underscore that the general risk of transmission is low and that it takes place through close, direct and prolonged personal contact through things like kissing or sharing vapes and drinks. We need to get the balance right between promoting awareness—people thinking about their own situation and whether any of these factors apply to them—and not spreading unnecessary anxiety, because most people, including the overwhelming majority of students at the universities and people in Canterbury, will not be at risk.

[Kirsty Blackman (Aberdeen North) (SNP)]

Our thoughts are with everyone involved in this matter, particularly all those who are dealing with it, including medical professionals, university staff and UKHSA. I understand that the Secretary of State’s immediate priority today will be this specific outbreak. Dr Amirthalingam from UKHSA was on BBC Radio 4 this morning and suggested that the progression of the outbreak is atypical. Will the Secretary of State give a reassurance that the devolved health authorities will be given updates if there is another atypical progression anywhere else in these islands?

[Wes Streeting]

The hon. Member is absolutely right about the atypical nature of this outbreak. I can reassure her and the House that UKHSA is in regular contact with the devolved Administrations.

Puberty Suppressants Trial

Debate between Kirsty Blackman and Wes Streeting

Wednesday 17th December 2025 Commons Chamber

[Wes Streeting]

I am grateful to my hon. Friend for his question. The reassurance that we can provide trans people in our country is that we are committed to making sure that they have access to the highest quality, evidence-based healthcare. That does not just apply in the case of children and young people; I also hope to report to the House before the Christmas recess the work undertaken in the learning disability mortality review into adult services. We are committed to making sure that we provide high-quality care to a particular vulnerable group of children and young people.

[Kirsty Blackman (Aberdeen North) (SNP)]

Although I disagreed with the permanent ban, it is to the Secretary of State’s credit that he has been very clear about all the competing issues that he is balancing to make his decisions, and I appreciate that. There are young people who are hoping to be part of the clinical trial and to receive puberty blockers, whether that will genuinely make a difference to their lives or they believe that it will make a difference to their lives. How will he ensure that appropriate support is given to those young people who do not get to be part of the trial, when they have been hoping that it will change their lives?

[Wes Streeting]

I am grateful to the hon. Member for the way that she asks her question, as a critic of some of the decisions that I have taken in this space. The reassurance that I can offer is that the study will look at the holistic care that this group of children and young people receives, and ensure that wider evidence-led therapeutic support, including mental health support, is available, so that regardless of whether a young person receives puberty blockers, they will certainly receive that wider range of support.

European Union (Withdrawal) Bill

Debate between Kirsty Blackman and Wes Streeting

Committee: 5th sitting: House of Commons
Wednesday 6th December 2017 Commons Chamber

[Kirsty Blackman]

I absolutely agree with the hon. Gentleman, with whom I used to serve on the Scottish Affairs Committee. This does need to be as transparent as possible. Every bit of money that is agreed between the UK Government and the EU as part of the withdrawal settlement needs to be itemised. We need to know what the UK is agreeing to pay for and the timescale over which we will be paying it.

[Wes Streeting]

I entirely agree with the points that the hon. Lady is making. It was interesting that this afternoon in the Treasury Committee, the Chancellor acknowledged that the cost to the UK of settling any outstanding debts with the European Union will be small beer compared with the costs if we do not get a good long-term trading relationship with the EU. There are two issues: the short-term cost and the impact on the scorecard, and the long-term cost to the economy and the damage that that will do if we cannot move on to phase 2 of these talks.

[Kirsty Blackman]

I absolutely agree. I will come on to the more indirect costs in a moment, but first I want to mention one more thing in relation to direct costs.

There is still ongoing uncertainty about the replacements, or possible replacements, for EU structural funds—for example, the Horizon 2020 money, the social fund and the common agricultural policy payments. We have a level of certainty on some of those in the very short term, but what happens after April 2019? What happens to the projects that currently receive money, or are likely to be bidding for money in future? What are the UK Government going to do to replace those funds? We do not have any certainty on the replacements for most of the direct funding.

I now move on to the indirect costs of Brexit. I am totally baffled as to whether or not there are economic impact assessments. The UK Government told us that there were impact assessments. They were incredibly clear that there were impact assessments and so they definitely knew how this was going to impact on the economy. Then, at the Brexit Committee, the Secretary of State said that there are no economic impact assessments. Any kind of responsible organisation does an economic impact assessment—before it takes an action, preferably. If an organisation is in this crazy situation where it has signed up to an action and drawn all these ridiculous red lines, it will probably be wise to do the economic impact assessments then so that it has an idea of quite how much of a mess it has got itself into.